Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 31, 2006
Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cellsChary López-Pedrera, Paula Buendía, Nuria Barbarroja, et al.
Frontiers in Immunology|May 2, 2019
New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics ApproachesChary Lopez-Pedrera, Nuria Barbarroja, Alejandra Mª Patiño-Trives, et al.
Rheumatology (Oxford, England)|March 29, 2016
Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approachesChary López-Pedrera, Nuria Barbarroja, Yolanda Jimenez-Gomez, et al.
Hematological Oncology|November 28, 2006
Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small-molecule inhibitorsEmilio Siendones, Nuria Barbarroja, Luis Arístides Torres, et al.
Leukemia & Lymphoma|June 20, 2007
Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemiaNuria Barbarroja, Luis Arístides-Torres, Vanessa Hernandez, et al.
Chemico-Biological Interactions|May 4, 2010
ES936 stimulates DNA synthesis in HeLa cells independently on NAD(P)H:quinone oxidoreductase 1 inhibition, through a mechanism involving p38 MAPKDavid González-Aragón, Francisco J Alcaín, Julia Ariza, et al.
Autoimmunity Reviews|September 16, 2018
Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targetsIrene Cecchi, Ivan Arias de la Rosa, Elisa Menegatti, et al.
Experimental Neurology|July 10, 2012
Ablation of PGC1 beta prevents mTOR dependent endoplasmic reticulum stress responseAlberto Camacho, Sergio Rodriguez-Cuenca, Margaret Blount, et al.
International Journal of Molecular Sciences|December 2, 2020
Effects of Biological Therapies on Molecular Features of Rheumatoid ArthritisChary Lopez-Pedrera, Nuria Barbarroja, Alejandra M Patiño-Trives, et al.
Frontiers in Immunology|October 10, 2022
Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular riskNuria Barbarroja, Miriam Ruiz-Ponce, Laura Cuesta-López, et al.
Pageof 9